glp-1 elevated liver enzymes Multiple target tissue effects of analogues on non-alcoholic fatty disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Semaglutide-Induced Liver Injury - PMC

Description

Sergey Terushkin, MD, FACS, leads our telehealth medical weight loss program, offering personalized, prescription-based treatment plans tailored to each patients medical history, weight loss goals, and clinical evaluation

Here is what the clinical evidence consistently shows: Significant, sustained weight loss The STEP clinical trials for semaglutide showed average weight loss of 14.9% of body weight over 68 weeks more than double the typical result from traditional dieting programs

We do not know for sure why these specific items may lead to diverticulitis, but the leading theories suggest these items either lead to decreased blood flow to the diverticula or increase the pressure inside the diverticula, which leads to inflammation and subsequent infection, he explains